Clinical Trial Update: Contrast-Enhanced Ultrasound for the Prediction of Bile Duct Cancer Response to Radioembolization Treatment [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated Contrast-Enhanced Ultrasound as a predictor of response to radioembolization in intrahepatic cholangiocarcinoma, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Snippet

Sponsor: Thomas Jefferson University | Conditions: Intrahepatic Cholangiocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2025-10-28